News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 217–252
- Matches
- 1086
- Sources here
- 20
- Companies here
- 17
Search results
Stored financial headlines
Active search
1086 matching headlines
Ticker or company: VIRMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
AVAV Outperforms Industry in the Past Month: How to Play the Stock?
AeroVironment, Inc. AVAV stock has gained 35.1% in the past month, outpacing both the Zacks Aerospace-Defense Equipment industry's growth of 3.9% and the broader Zacks Aerospace sector's gain of 6.8%. It also came above the Zacks S&P 500 composite's return of 2% in the …
AVAV
main company
Sharemaestro market context
Price below Trend Line
52 weeks -19.6%
Virtuix to Highlight Accelerating Consumer Growth and Expansion Across Defense, Robotics, and Healthcare at Sidoti Investor Conference
Virtuix, Inc. AUSTIN, Texas, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Virtuix Holdings Inc. (NASDAQ: VTIX), a leading developer of AI-driven, full-body simulation systems, today announced that Virtuix's Founder, Chief Executive Officer, and Chairman, Jan Goetgeluk, will present at Sidoti's Micro-Cap Virtual Investor Conference on …
VTIX
main company
Sharemaestro market context
Stored weekly price path
29 weeks -73.7% · Next-week setup negative 43.8%
CECO Environmental (NASDAQ:CECO) Downgraded to "Hold" Rating by Zacks Research
Zacks Research downgraded CECO Environmental (NASDAQ:CECO) from "strong buy" to "hold," despite the broader analyst consensus remaining a "Moderate Buy" with an average price target of $104. The company recently reported strong quarterly earnings, exceeding analyst expectations with $0.47 per share and $284.96 million …
CECO
main company
Sharemaestro market context
Trend signal started
52 weeks +65.9% · Next-week setup positive 56.7%
Virginia National Bankshares Reports Q2 2026 Financial Results in SEC 10-Q Filing
Virginia National Bankshares Corporation (NASDAQ:VABK) has filed its Q2 2026 Form 10-Q, detailing financial performance for the period ending June 30, 2026. Key highlights include total assets of $1.638 billion, a net interest income of $26.655 million, and a significant gain of $4.662 million …
VABK
main company
Sharemaestro market context
Trend signal active
52 weeks +13.4%
Virgin Galactic forecasts positive quarterly cash flow within 2027 as first commercial spaceflight shifts to February
Earnings Call Insights: Virgin Galactic (SPCE) Q2 2026 MANAGEMENT VIEW * "I'm pleased to share our recent tranche of spaceflight expeditions has booked out ahead of schedule" and "the allotment we had held at the $750,000 price point was oversubscribed" (CEO, President & Director …
Sharemaestro market context Price above Trend Line 52 weeks -2.8% · Next-week setup negative 41.2%Viridian Therapeutics, Inc. Stock 12‑Month Price Target Cut to $36.07, Implies 58% Upside
The average 12-month price target for Viridian Therapeutics, Inc. (VRDN) stock has been lowered to $36.07 from $36.81 by 15 analysts, suggesting a potential upside of approximately 58% from its August 12 closing price. Despite the target cut, the consensus rating from 17 covering …
VRDN
main company
Sharemaestro market context
Price above Trend Line
52 weeks +14.9%
Perma-Fix Environmental Services Inc (PESI) (Q2 2026) Earnings Call Highlights: Hanford ...
Perma-Fix Environmental Services Inc (PESI) discussed its Q2 2026 earnings, highlighting a significant $4.4 billion master IDIQ subcontract for the Hanford tank waste grouting program and a 29% growth in treatment backlog. Despite a revenue shortfall and net loss in Q2 due to customer-directed …
PESI
main company
Sharemaestro market context
Trend signal active
52 weeks +42.8%
Perma-Fix Environmental Services Q2 Earnings Call Highlights
Perma-Fix Environmental Services Inc (PESI) discussed its Q2 2026 earnings, highlighting a significant $4.4 billion master IDIQ subcontract for the Hanford tank waste grouting program and a 29% growth in treatment backlog. Despite a revenue shortfall and net loss in Q2 due to customer-directed …
PESI
main company
Sharemaestro market context
Trend signal active
52 weeks +42.8%
Virtus Investment Partners reports July AUM of $148.9 billion By Investing.com
Virtus Investment Partners reported preliminary assets under management (AUM) of $148.9 billion and other fee-earning assets of $1.7 billion as of July 31, 2026, totaling $150.6 billion in client assets. This marks a decrease from $152.2 billion in June, primarily due to market performance …
VRTS
main company
Sharemaestro market context
Trend signal active
52 weeks -11.7% · Next-week setup positive 55.4%
Certain Warrants of Perma-Fix Environmental Services, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2026.
Certain Warrants of Perma-Fix Environmental Services, Inc. (PESI) are currently under a 91-day lock-up agreement. This lock-up started on May 14, 2026, and will conclude on August 13, 2026. During this period, company directors and executive officers are restricted from selling or transferring common …
PESI
main company
Sharemaestro market context
Trend signal active
52 weeks +42.8%
TOMI Environmental Solutions Inc expected to post a loss of 11 cents a share - Earnings Preview
TOMI Environmental Solutions Inc (TOMZ) is projected to report a loss of 11 cents per share, according to an earnings preview. This information was reported by Reuters and is available on TradingView, which aggregates news from various sources. The full article provides more details …
TOMZ
main company
Sharemaestro market context
Price below Trend Line
52 weeks -31.5%
AeroVironment (AVAV) Stock Declines While Market Improves: Some Information for Investors
AeroVironment (AVAV) closed at $193.81 in the latest trading session, marking a -1.13% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 0.26%. Meanwhile, the Dow lost 0.04%, and the Nasdaq, a tech-heavy index, added 0.54%. …
AVAV
main company
Sharemaestro market context
Price below Trend Line
52 weeks -19.6%
Vir Biotechnology (VIR) Q2 2026 Earnings Call Transcript
Vir Biotechnology (VIR) reported significant financial improvements in Q2 2026, with $1.01 billion in cash and investments and $238.9 million in revenue, driven by a collaboration with Astellas. The company highlighted strong progress in its hepatitis delta program, with promising clinical trial results for …
VIR
main company
Sharemaestro market context
Trend signal ended
52 weeks +101.7%
Virgin Galactic (SPCE) Reports Q2 Loss, Beats Revenue Estimates
Virgin Galactic (SPCE) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.6. This compares to a loss of $1.47 per share a year ago. These figures are adjusted for non-recurring items. This quarterly …
Sharemaestro market context Price above Trend Line 52 weeks -2.8% · Next-week setup negative 41.2%Perma-Fix Reports Second Quarter 2026 Results, Award of Hanford Master IDIQ Subcontract and Commencement of DFLAW Waste Receipts
Perma-Fix Environmental Services, Inc. reported its second quarter 2026 financial results, which did not meet expectations but included significant operational milestones. The company announced the award of a Master IDIQ Subcontract for waste treatment at the Hanford Site, with task orders potentially starting in …
PESI
main company
Sharemaestro market context
Trend signal active
52 weeks +42.8%
Vir Biotechnology (VIR) director restructures 16,000-share holding with Alta Partners fund
Vir Biotechnology, Inc. director Robert J. More reported internal share transfers totaling 16,000 shares of common stock, executed on August 11, 2026. These transactions involved transferring shares held for Alta Partners NextGen Fund I, L.P. (APNG 1) for no consideration in connection with the …
VIR
main company
Sharemaestro market context
Trend signal ended
52 weeks +101.7%
Vir Biotechnology: Astellas Deal Pushes Cash Above $1 Billion And Extends Runway Into Second Half Of 2028
Vir Biotechnology's cash reserves exceeded $1 billion in Q2 2026, extending its operational runway into late 2028, primarily due to a strategic collaboration with Astellas. This deal, involving a $240 million upfront payment and a $75 million equity investment, focuses on VIR-5500 for prostate …
VIR
main company
Sharemaestro market context
Trend signal ended
52 weeks +101.7%